German team unveils progress in pancreatic cancer staging
November 4, 2020 -- Investigators from Heidelberg University Hospital and the German Cancer Research Center are convinced that PET/CT using a fibroblast activation protein molecule inhibitor can open up new applications in staging and restaging of pancreatic ductal adenocarcinoma. Read More
Dutch use molecular scan to find new salivary glands
October 30, 2020 -- A group from the Netherlands Cancer Institute in Amsterdam has used PET/CT with a radiopharmaceutical based on a prostate-specific membrane antigen to discover a pair of salivary glands. Sparing these glands during radiation therapy may prevent treatment side effects and improve quality of life for head and neck cancer patients. Read More
PET/CT rules supreme in cases of neuroendocrine tumors
October 27, 2020 -- PET/CT has no rivals when it comes to the detection and surveillance of cardiac metastases in well-differentiated gastroenteropancreatic neuroendocrine tumors as well as guiding clinical management, according to research presented at the annual congress of the European Association of Nuclear Medicine. Read More
Dynamic PET edges closer to clinical prime time
October 27, 2020 -- Dynamic whole-body PET is evolving fast and showing considerable clinical promise, a leading French molecular imaging expert told the opening plenary session at the annual congress of the European Association of Nuclear Medicine. The technique is benefiting from artificial intelligence-based assistance to simplify the challenging and time-consuming tasks associated with the acquisition and analysis of data. Read More
PET moves ahead in detection of hypoxic tumors
October 21, 2020 -- Researchers have used PET to provide a new way to diagnose hypoxia in tumors. They demonstrated that signs of tumor hypoxia can be spotted among the gamma rays collected routinely during a PET scan, providing clinicians with extra information to guide treatment decisions. Read More
German group refines PET technique for prostate cancer
October 13, 2020 -- Researchers from Essen have used a PET-based optical imaging method known as Cerenkov luminescence imaging to highlight the presence of cancer cells after prostate cancer surgery. They published their results in the October edition of the Journal of Nuclear Medicine. Read More
Compton imaging opens up new diagnostic avenues
October 9, 2020 -- Compton imaging -- originally developed by astronomers for detecting gamma ray sources -- is now under investigation for clinical imaging. A high-performance Compton camera could prove invaluable for applications within nuclear medicine and molecular imaging, researchers have found. Read More
600+ km trek across the Himalayas for cancer therapy
September 23, 2020 -- It takes on average 18 hours by bus for patients to reach the cancer hospital in Nepal, and many of them travel over 600 km. Now the pandemic has made it even more difficult to get treatment, writes Tirthraj Adhikari, a medical physicist trained in Italy. He gives a personal account of the challenges faced by patients and staff. Read More
After Brexit: Device regulations come under scrutiny
September 15, 2020 -- The U.K. has produced advice on how to launch medical devices on the market after the Brexit transition period ends on 1 January 2021. Regulatory expert Mike Pogose discusses how the new procedures will affect imaging manufacturers and their customers. Read More
Dutch team unveils new findings on radiomics
September 14, 2020 -- Researchers from Amsterdam have found that molecular imaging can contribute to better treatment decisions for patients with head and neck squamous cell carcinoma by providing clinically valuable radiomics information on tumor phenotypes. Read More